In response to unproven claims regarding the use of Ivermectin as a preventive drug for Covid-19, the Health Ministry has announced plans to carry out randomised clinical trials to see if the drug can be used.

"The Ministry of Health (MOH) Malaysia has initiated a randomised clinical trial to repurpose Ivermectin and evaluate its efficacy and safety in high-risk Covid-19 patients.

"The trial will enrol 500 Covid-19 patients admitted to...